Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis | MicrobiomeTrials← Back to trialsNCT06864936
Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-05-01Est. Completion: 2027-12-30
Enrollment target: 30 participants Locations- University of Maryland, Baltimore, Baltimore, Maryland, United States
Other microbiome trials you might be interested in
Relapsing Remitting Multiple Sclerosis
The MS pilot study will assess the safety and investigate the remyelinating effects of the SetPoint System (study device…
Irvine, United StatesEst. completion Dec 31, 2027
Multiple Sclerosis
This single-blind, randomized controlled clinical trial aims to evaluate the long-term effects of using sensorimotor ins…
Salamanca, SpainEst. completion Dec 2026